Insider Transactions Reported by 17 Insiders of IN8BIO, INC.

Symbol
INAB on Nasdaq
Location
New York, NY

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

IN8BIO, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Aaron G.l. Fletcher 10%+ Owner $1,289,996 02 May 2025
Leslie W. Kreis 10%+ Owner $1,289,996 02 May 2025
Emily Fairbairn Director $999,999 22 Dec 2025
William Tai-Wei Ho CEO, Director, 10%+ Owner $189,468 04 Feb 2026
Peter C. Brandt Director $138,226 22 Dec 2025
Alan S. Roemer Director $68,329 22 Dec 2025
Patrick McCall Chief Financial Officer $13,085 04 Feb 2026
Kate Rochlin President and COO $12,537 04 Feb 2026
Trishna Goswami Chief Medical Officer $6,931 04 Sep 2024
Corinne Epperly Director 08 May 2025
Travis Whitfill Director 19 Dec 2024
Jeremy R. Graff Director 08 May 2025
Lawrence Lamb EVP and CSO 04 Feb 2026
Bios Equity Partners, LP 10%+ Owner 13 Aug 2021
Luba Greenwood Director 08 May 2025
Melissa Beelen VP, Clinical Operation 29 Jul 2021
Bios Clinical Opportunity Fund, LP 10%+ Owner 13 Dec 2023

Recent Insider Transactions by Companies or Individuals for IN8BIO, INC.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Lawrence Lamb INAB Employee Stock Option (right to buy) Award 72,000 72,000 04 Feb 2026 Direct
Patrick McCall INAB Employee Stock Option (right to buy) Award 75,000 75,000 04 Feb 2026 Direct
Kate Rochlin INAB Employee Stock Option (right to buy) Award 80,000 80,000 04 Feb 2026 Direct
William Tai-Wei Ho INAB Employee Stock Option (right to buy) Award 206,000 206,000 04 Feb 2026 Direct
Kate Rochlin INAB Common Stock Award 394.3% 7,247 9,085 22 Dec 2025 Direct
Patrick McCall INAB Common Stock Award 324.2% 7,247 9,482 22 Dec 2025 Direct
William Tai-Wei Ho INAB Common Stock Award 42.7% 36,232 121,168 22 Dec 2025 Direct
Alan S. Roemer INAB Common Stock Award 272.8% 36,232 49,514 22 Dec 2025 Direct
Peter C. Brandt INAB Common Stock Award 319% 72,464 95,181 22 Dec 2025 Direct
Emily Fairbairn INAB Common Stock Award 724,637 724,637 22 Dec 2025 See footnote
Luba Greenwood INAB Stock Option (right to buy) Award 63,150 63,150 08 May 2025 Direct
Jeremy R. Graff INAB Stock Option (right to buy) Award 63,150 63,150 08 May 2025 Direct
Emily Fairbairn INAB Stock Option (right to buy) Award 63,150 63,150 08 May 2025 Direct
Corinne Epperly INAB Stock Option (right to buy) Award 63,150 63,150 08 May 2025 Direct
Peter C. Brandt INAB Stock Option (right to buy) Award 63,150 63,150 08 May 2025 Direct
Alan S. Roemer INAB Stock Option (right to buy) Award 63,150 63,150 08 May 2025 Direct
Aaron G.l. Fletcher INAB Series B Warrant Other -100% -574,241 0 02 May 2025 By Bios Clinical Opportunity Fund, LP
Aaron G.l. Fletcher INAB Series A Warrant Other -100% -574,241 0 02 May 2025 By Bios Clinical Opportunity Fund, LP
Aaron G.l. Fletcher INAB Pre-Funded Warrants Purchase 89.5% 1,148,482 2,431,763 02 May 2025 By Bios Clinical Opportunity Fund, LP
Leslie W. Kreis INAB Series B Warrant Other -100% -574,241 0 02 May 2025 By Bios Clinical Opportunity Fund, LP
Leslie W. Kreis INAB Series A Warrant Other -100% -574,241 0 02 May 2025 By Bios Clinical Opportunity Fund, LP
Leslie W. Kreis INAB Pre-Funded Warrants Purchase 89.5% 1,148,482 2,431,763 02 May 2025 By Bios Clinical Opportunity Fund, LP
William Tai-Wei Ho INAB Pre-Funded Warrant (right to buy) Award 81,967 81,967 01 May 2025 Direct
William Tai-Wei Ho INAB Series A Warrants (right to buy) Disposed to Issuer -100% -81,967 0 01 May 2025 Direct
Kate Rochlin INAB Common Stock Options Exercise 28.7% 12,295 55,169 30 Apr 2025 Direct
Kate Rochlin INAB Series A Warrants (right to buy) Options Exercise -100% -12,295 0 30 Apr 2025 Direct
Patrick McCall INAB Common Stock Options Exercise 28.8% 15,000 67,071 30 Apr 2025 Direct
Patrick McCall INAB Series A Warrants (right to buy) Options Exercise -100% -15,000 0 30 Apr 2025 Direct
Alan S. Roemer INAB Common Stock Options Exercise 39.8% 113,459 398,489 30 Apr 2025 Direct
Alan S. Roemer INAB Series B Warrants (right to buy) Options Exercise -100% -11,000 0 30 Apr 2025 Direct
Alan S. Roemer INAB Series A Warrants (right to buy) Options Exercise -100% -102,459 0 30 Apr 2025 Direct
Peter C. Brandt INAB Common Stock Options Exercise 31.7% 163,934 681,538 30 Apr 2025 Direct
Peter C. Brandt INAB Series B Warrants (right to buy) Options Exercise -100% -81,967 0 30 Apr 2025 Direct
Peter C. Brandt INAB Series A Warrants (right to buy) Options Exercise -100% -81,967 0 30 Apr 2025 Direct
Lawrence Lamb INAB Series B Warrants (right to buy) Award 1,639 1,639 27 Apr 2025 Direct
Lawrence Lamb INAB Series B Warrants (right to buy) Disposed to Issuer -100% -1,639 0 27 Apr 2025 Direct
Jeremy R. Graff INAB Series B Warrants (right to buy) Award 2,049 2,049 27 Apr 2025 Direct
Jeremy R. Graff INAB Series B Warrants (right to buy) Disposed to Issuer -100% -2,049 0 27 Apr 2025 Direct
Corinne Epperly INAB Series B Warrants (right to buy) Award 81,967 81,967 27 Apr 2025 Direct
Corinne Epperly INAB Series B Warrants (right to buy) Disposed to Issuer -100% -81,967 0 27 Apr 2025 Direct
William Tai-Wei Ho INAB Series B Warrants (right to buy) Award 81,967 81,967 27 Apr 2025 Direct
William Tai-Wei Ho INAB Series B Warrants (right to buy) Disposed to Issuer -100% -81,967 0 27 Apr 2025 Direct
Kate Rochlin INAB Series B Warrants (right to buy) Award 12,295 12,295 27 Apr 2025 Direct
Kate Rochlin INAB Series B Warrants (right to buy) Disposed to Issuer -100% -12,295 0 27 Apr 2025 Direct
Kate Rochlin INAB Series A Warrants (right to buy) Award 12,295 12,295 27 Apr 2025 Direct
Kate Rochlin INAB Series A Warrants (right to buy) Disposed to Issuer -100% -12,295 0 27 Apr 2025 Direct
Patrick McCall INAB Series B Warrants (right to buy) Award 20,492 20,492 27 Apr 2025 Direct
Patrick McCall INAB Series B Warrants (right to buy) Disposed to Issuer -100% -20,492 0 27 Apr 2025 Direct
Patrick McCall INAB Series A Warrants (right to buy) Award 15,000 15,000 27 Apr 2025 Direct
Patrick McCall INAB Series A Warrants (right to buy) Disposed to Issuer -73.2% -15,000 5,492 27 Apr 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.